Lord P G, Hardaker K J, Loughlin J M, Marsden A M, Orton T C
Safety of Medicines Department, ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Carcinogenesis. 1992 Aug;13(8):1383-7. doi: 10.1093/carcin/13.8.1383.
The high incidence and profile of ras gene mutations reported in spontaneous and chemically induced liver tumours of the B6C3F1 mouse provides a potential means of determining in vivo genotoxicity and its relevance to carcinogenicity. We analysed spontaneous and chemically induced [with 4-amino-biphenyl (ABP), 2-acetylaminofluorene (AAF) and diethylnitrosamine (DEN)] hepatocellular tumours of the C57Bl/10J mouse for H-ras, K-ras and N-ras gene mutations to see if mutational analysis of the ras genes could be useful for such a determination in this strain. Regions of DNA spanning codons 12, 13 and 61 of the ras genes were amplified from formalin fixed liver tumour sections using the polymerase chain reaction. Mutations were detected using allele specific oligonucleotide probing and confirmed by sequencing. We have found that there are few ras mutations in either spontaneous or chemically induced liver tumours in the C57Bl/10J mouse. Out of 25 spontaneous tumours two contained an A to T transversion and one contained an A to G transition in base 2 of H-ras codon 61 and two contained a G to A transition in base 2 of K-ras codon 13 (the K-ras mutations were only faintly detectable and may be present in a subpopulation of the tumour cells). In the case of the 18 ABP induced tumours one contained a C to A transversion in base 1 of H-ras codon 61, and one contained an A to T transversion in base 2 of H-ras codon 61 and one contained a G to C transversion in base 1 of K-ras codon 13. One C to A transversion in base 1 of H-ras codon 61 was detected out of eight AAF induced tumours. Of the 25 DEN induced tumours, one contained an A to G transition and one contained an A to C transversion in base 2 of H-ras codon 61. The data indicate that at least in hepatocellular tumours of the C57Bl/10J strain and using chronic dosing regimes the ras genes do not represent markers for in vivo genotoxic activity.
在B6C3F1小鼠的自发和化学诱导性肝肿瘤中报道的ras基因突变的高发生率和特征,为确定体内遗传毒性及其与致癌性的相关性提供了一种潜在方法。我们分析了C57Bl/10J小鼠的自发和化学诱导(用4-氨基联苯(ABP)、2-乙酰氨基芴(AAF)和二乙基亚硝胺(DEN))的肝细胞肿瘤中的H-ras、K-ras和N-ras基因突变,以观察ras基因的突变分析对于该品系的这种确定是否有用。使用聚合酶链反应从福尔马林固定的肝肿瘤切片中扩增跨越ras基因密码子12、13和61的DNA区域。使用等位基因特异性寡核苷酸探针检测突变并通过测序进行确认。我们发现,在C57Bl/10J小鼠的自发或化学诱导性肝肿瘤中几乎没有ras突变。在25个自发肿瘤中,两个在H-ras密码子61的第2位碱基处有一个A到T的颠换,一个有一个A到G的转换,两个在K-ras密码子13的第2位碱基处有一个G到A的转换(K-ras突变仅微弱可检测,可能存在于肿瘤细胞的一个亚群中)。在18个ABP诱导的肿瘤中,一个在H-ras密码子61的第1位碱基处有一个C到A的颠换,一个在H-ras密码子61的第2位碱基处有一个A到T的颠换,一个在K-ras密码子13的第1位碱基处有一个G到C的颠换。在8个AAF诱导的肿瘤中,检测到一个在H-ras密码子61的第1位碱基处有一个C到A的颠换。在25个DEN诱导的肿瘤中,一个在H-ras密码子61的第2位碱基处有一个A到G的转换,一个有一个A到C的颠换。数据表明,至少在C57Bl/10J品系的肝细胞肿瘤中,并且使用慢性给药方案时,ras基因不代表体内遗传毒性活性的标志物。